AIDS settlement offer: a hard choice for hemophiliacs

Article Abstract:

U.S. hemophiliacs who were infected by HIV-tainted blood product have been offered a settlement of about $100,000 each by the drug company defendants. The offer must be accepted by 95% of the 800 people with pending lawsuits against the companies. The companies are accused of knowingly selling AIDS-tainted clotting factors in the early 1980s. The defendants in the cases are Bayer AG; Baxter International Inc.; Rhone-Poulenc Rorer Inc.; and Alpha Therapeutics Inc., a division of Japan's Green Cross.

Biological Product (except Diagnostic) Manufacturing, Pharmaceutical Preparations, Biological products exc. diagnostic, Antihemophiliac Factor, Cases, Pharmaceutical industry, Drugs, HIV infection, HIV infections, Bayer AG, Blood coagulation factors, Factor VIII, Baxter International Inc. (Deerfield, Illinois), BAX, Hemophiliacs, Rhone-Poulenc Rorer Inc., RPR, Alpha Therapeutics Inc., Green Cross Corp.

---

Cholesterol drugs tied to cancer in rats; link questioned

Article Abstract:

Drugs to lower cholesterol levels in the 'fibric acid' and 'statin' categories have been found to cause cancer in laboratory mice and rats. The drugs were tested by the US Food and Drug Administration for less than 10 years. The drugs are not expected to cause cancer in humans before 20 years. The information was published in the Journal of the American Medical Assn for Jan 3, 1996.

Lipotropics & Cholesterol Reducers, Causes of, Physiological aspects, Cancer, Anticholesteremic agents

---

Similar abstracts:

• Abstracts: Industry doom overstated? Agencies join forces to stop rogue online pharmacies. Reinventing the detailer

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.